3645 results for «737»

Filter By

3645 results

Interventions for heart failure: shock and beyond

20 May 2026 – From EuroPCR 2026

Focused on interventions for heart failure, this session presents data on mitral regurgitation post-alcohol septal ablation, outcomes from high-risk PCI supported by Impella CP, evolving trends in ECMO utilization for cardiogenic shock, and six-month patient outcomes guided by shock team management strategies.

Best cases in stable CAD

20 May 2026 – From EuroPCR 2026

This session showcases exemplary cases in stable coronary artery disease, emphasizing complex diagnostic and therapeutic challenges such as ambiguous angiographic findings, refractory vasospastic angina, catastrophic no-reflow phenomena, and the application of physiology-guided PCI and coronary sinus reducers.

New frontiers - The evolving role of nurses and allied professionals

20 May 2026 – From EuroPCR 2026

This session explores the evolving role of nurses and allied professionals in interventional cardiology, addressing challenges in role definitions, collaborative responsibilities with physicians, and strategies for professional recognition and safety enhancement within the cath lab environment.

Redo TAVI challenges

20 May 2026 – From EuroPCR 2026

Focused on the complexities of redo transcatheter aortic valve implantation (TAVI), this session covers innovative techniques such as jailed-balloon to prevent sinus sequestration, CT-guided emergency valve-in-valve procedures, alternative access routes, and strategies to manage coronary occlusion risks during multiple valve interventions.

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial
Didn’t find what you were looking for?